Last reviewed · How we verify
mepacrine
mepacrine is a drug. It is currently in unknown development for Giardiasis.
At a glance
| Generic name | mepacrine |
|---|---|
| Target | Aldehyde oxidase, Major prion protein, 5-hydroxytryptamine receptor 2A |
| Therapeutic area | Other |
| Phase | unknown |
Approved indications
- Giardiasis
Common side effects
Key clinical trials
- An Open-Label, Phase II Safety, Tolerability, Drug Level and Efficacy Trial of Quinacrine in Patients With Androgen-Independent Metastatic Prostate Cancer (Phase 2)
- An Open-label, Fixed-dose, Clinical Study of Quinacrine Safety and Efficacy in the Treatment of Advanced Renal Cell Carcinoma (Phase 2)
- Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma:A Phase I/II Investigator-Initiated Clinical Trial (Phase 1)
- A Phase I Study of Erlotinib in Combination With Quinacrine in Patients With Advanced Non-Small-Cell Lung Cancer (Phase 1)
- PRION-1: Quinacrine for Human Prion Disease. A Partially Randomized Patient Preference Trial to Evaluate the Activity and Safety of Quinacrine in Human Prion Disease (NA)
- Novel Therapeutics For Prion Diseases: A Randomized, Double-blinded, Placebo-controlled Study of the Efficacy of Quinacrine in the Treatment of Sporadic Creutzfeldt-Jakob Disease (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- mepacrine CI brief — competitive landscape report
- mepacrine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about mepacrine
What is mepacrine?
mepacrine is a pharmaceutical drug, indicated for Giardiasis.
What is mepacrine used for?
mepacrine is indicated for Giardiasis.
What development phase is mepacrine in?
mepacrine is in unknown.
What does mepacrine target?
mepacrine targets Aldehyde oxidase, Major prion protein, 5-hydroxytryptamine receptor 2A.
Related
- Target: All drugs targeting Aldehyde oxidase, Major prion protein, 5-hydroxytryptamine receptor 2A
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
- Indication: Drugs for Giardiasis
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing